Hepatitis B virus: from immunobiology to immunotherapy

被引:22
作者
Grimm, Daniel [1 ]
Heeg, Maximilian [1 ]
Thimme, Robert [1 ]
机构
[1] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany
关键词
hepatitis B virus (HBV); immunity; immunobiology; infection; liver disease; T-CELL RESPONSES; ADAPTIVE IMMUNE-RESPONSES; LAMIVUDINE TREATMENT; VIRAL PERSISTENCE; X PROTEIN; INFECTION; EXPRESSION; INNATE; ACTIVATION; REPLICATION;
D O I
10.1042/CS20120169
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Owing to the major limitations of current antiviral therapies in HBV (hepatitis B virus) infection, there is a strong need for novel therapeutic approaches to this major health burden. Stimulation of the host's innate and adaptive immune responses in a way that results in the resolution of viral infection is a promising approach. A better understanding of the virus-host interaction in acute and chronic HBV infection revealed several possible novel targets for antiviral immunotherapy. In the present review, we will discuss the current state of the art in HBV immunology and illustrate how control of infection could be achieved by immunotherapeutic interventions.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 92 条
[1]
Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]
The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection [J].
Asabe, Shinichi ;
Wieland, Stefan F. ;
Chattopadhyay, Pratip K. ;
Roederer, Mario ;
Engle, Ronald E. ;
Purcell, Robert H. ;
Chisari, Francis V. .
JOURNAL OF VIROLOGY, 2009, 83 (19) :9652-9662
[3]
Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[4]
Bertoletti A., 2011, GUT, DOI [10.1136/gutjnl-2011-301073, DOI 10.1136/GUTJNI-2011-301073]
[5]
The host-pathogen interaction during HBV infection: immunological controversies [J].
Bertoletti, Antonio ;
Maini, Mala K. ;
Ferrari, Carlo .
ANTIVIRAL THERAPY, 2010, 15 :15-24
[6]
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo [J].
Blattman, JN ;
Grayson, JM ;
Wherry, EJ ;
Kaech, SM ;
Smith, KA ;
Ahmed, R .
NATURE MEDICINE, 2003, 9 (05) :540-547
[7]
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy [J].
Boni, C ;
Penna, A ;
Ogg, GS ;
Bertoletti, A ;
Pilli, M ;
Cavallo, C ;
Cavalli, A ;
Urbani, S ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
HEPATOLOGY, 2001, 33 (04) :963-971
[8]
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B [J].
Boni, C ;
Bertoletti, A ;
Penna, A ;
Cavalli, A ;
Pilli, M ;
Urbani, S ;
Scognamiglio, P ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :968-975
[9]
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B [J].
Boni, C ;
Penna, A ;
Bertoletti, A ;
Lamonaca, V ;
Rapti, I ;
Missale, G ;
Pilli, M ;
Urbani, S ;
Cavalli, A ;
Cerioni, S ;
Panebianco, R ;
Jenkins, J ;
Ferrari, C .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :595-605
[10]
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection [J].
Boni, Carolina ;
Fisicaro, Paola ;
Valdatta, Caterina ;
Amadei, Barbara ;
Di Vincenzo, Paola ;
Giuberti, Tiziana ;
Laccabue, Diletta ;
Zerbini, Alessandro ;
Cavalli, Albertina ;
Missale, Gabriele ;
Bertoletti, Antonio ;
Ferrari, Carlo .
JOURNAL OF VIROLOGY, 2007, 81 (08) :4215-4225